10.1161/CIRCULATIONAHA.107.739938
All thanks to the group of drugs termed Glucagon-like Peptide-1 (GLP1) agonists (like Ozempic, Wegovy), which lower blood sugar levels, promote weight loss by enhancing insulin secretion, reduce appetite, and slow digestion
Practical steps: Have your insurance card and diagnosis codes ready when enrolling
In rodent models, a number of studies have found that GLP-/GIP dual agonists group mice have reduced fat mass, decreased circulating cholesterol, and lost weight, which has excellent weight loss effect
A 2018 review similarly found that ALA resulted in more weight loss compared to placebo
Do I have to change my diet if I use Rybelsus (Semaglutide)